recombinant super-compound interferon
Term · Oncology and biomedicine · MLC-T-ONC-016458
A recombinant form of the naturally-occurring cytokine interferon-alpha (IFN-a) that has a modified spatial configuration, with immunomodulating, antiviral and antineoplastic activities. Upon administration of recombinant super-compound interferon (rSIFN-co), this agent binds to IFN-specific cell surface receptors, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune-modulating effects. The 3-dimensional conformational change improves efficacy and causes fewer side effects compared to IFN-a.
| Identifier | MLC-T-ONC-016458 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | rSIFN-co; recombinant super compound interferon |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016458",
"term": "recombinant super-compound interferon",
"field": "Oncology and biomedicine",
"definition": "A recombinant form of the naturally-occurring cytokine interferon-alpha (IFN-a) that has a modified spatial configuration, with immunomodulating, antiviral and antineoplastic activities. Upon administration of recombinant super-compound interferon (rSIFN-co), this agent binds to IFN-specific cell surface receptors, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune-modulating effects. The 3-dimensional conformational change improves efficacy and causes fewer side effects compared to IFN-a.",
"synonyms": [
"rSIFN-co",
"recombinant super compound interferon"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-super-compound-interferon/"
}
Record 14,208 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.